Radiofrequency ablation of liver metastasis: potential impact on immune checkpoint inhibitor therapy

Yasunori Minami; Naoshi Nishida; Masatoshi Kudo

doi:10.1007/s00330-019-06189-6

Related publications

Article2020

Endoscopic ultrasound-guided radiofrequency ablation of porcine liver

Shuya Maeshima, Yoshiyuki Ida, Ryo Shimizu, Yuki Kawaji, Takashi Tamura, Junya Nuta, Keiichi Hatamaru, Masahiro Itonaga, Masatoshi Kudo, Masayuki Kitano

Article2022

How Compatible Are Immune Checkpoint Inhibitors and Thermal Ablation for Liver Metastases?

Yasunori Minami, Haruyuki Takaki, Koichiro Yamakado, Masatoshi Kudo

Article2024

Impact of underlying liver disease on unresectable hepatocellular carcinoma treated with immune checkpoint inhibitors

Linda Y. Wu, Sarah Cappuyns, Amanda S. Loh, Sean Sun, Sara Lewis, Max W. Sung, Myron Schwartz, Josep M. Llovet, Deirdre Jill Cohen

BJC Reports

Article2022

Patterns and outcomes of subsequent therapy after immune checkpoint inhibitor discontinuation in HCC

Rohini Sharma, Anjana Pillai, Thomas U. Marron, Petros Fessas, Anwaar Saeed, Tomi Jun, Sirish Dharmapuri, David Szafron, Abdul Rafeh Naqash, Anuhya Gampa, Yinghong Wang, Uqba Khan, Mahvish Muzaffar, C.C. Lee, Pei‐Chang Lee, Anushi Bulumulle, Sonal Paul, Dominic Bettinger, Hannah Hildebrand, Mohammed Yehia, Tiziana Pressiani, Ahmed O. Kaseb, Yi‐Hsiang Huang, Celina Ang, ,

Article2016

US-US Fusion Imaging in Radiofrequency Ablation for Liver Metastases

Yasunori Minami, Tomohiro Minami, Hirokazu Chishina, Masashi Kono, Tadaaki Arizumi, Masahiro Takita, Norihisa Yada, Satoru Hagiwara, Hiroshi Ida, Kazuomi Ueshima, Naoshi Nishida, Masatoshi Kudo